Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.

This publication has 47 references indexed in Scilit:

• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Identification of proliferating dendritic cell precursors in mouse blood.
  The Journal of Experimental Medicine, 1992
• Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells
  International Journal of Cancer, 1992
• Tumor antigen presentation by murine epidermal cells.
  The Journal of Immunology, 1991
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991
• Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
  The Journal of Experimental Medicine, 1990
• Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.
  The Journal of Experimental Medicine, 1990
• Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.
  The Journal of Experimental Medicine, 1990
• Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.
  Journal of Clinical Investigation, 1990
• Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses
  European Journal of Immunology, 1988